+

WO1999002030A1 - MONOTERPENES SYNTHASES TIREES DE SAPIN GRANDISSIME (Abies grandis) - Google Patents

MONOTERPENES SYNTHASES TIREES DE SAPIN GRANDISSIME (Abies grandis) Download PDF

Info

Publication number
WO1999002030A1
WO1999002030A1 PCT/US1998/014528 US9814528W WO9902030A1 WO 1999002030 A1 WO1999002030 A1 WO 1999002030A1 US 9814528 W US9814528 W US 9814528W WO 9902030 A1 WO9902030 A1 WO 9902030A1
Authority
WO
WIPO (PCT)
Prior art keywords
seq
synthase
gymnosperm
monoteφene
sequence
Prior art date
Application number
PCT/US1998/014528
Other languages
English (en)
Inventor
Joerg Bohlmann
Christopher L. Steele
Rodney B. Croteau
Original Assignee
Washington State University Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Washington State University Research Foundation filed Critical Washington State University Research Foundation
Priority to AU84839/98A priority Critical patent/AU8483998A/en
Priority to EP98935641A priority patent/EP1032257A4/fr
Priority to CA002296664A priority patent/CA2296664A1/fr
Publication of WO1999002030A1 publication Critical patent/WO1999002030A1/fr
Priority to US09/360,545 priority patent/US6429014B1/en
Priority to PCT/US2000/020264 priority patent/WO2001007565A2/fr
Priority to US10/025,145 priority patent/US20030175861A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)

Definitions

  • the present invention relates to nucleic acid sequences which code for monoterpene synthases from gymnosperm plant species, in particular from Grand fir (Abies grandis), including limonene synthase, myrcene synthase, and pinene synthase, to vectors containing the sequences, to host cells containing the sequences, to plant seeds expressing the sequences and to methods of producing recombinant monoterpene synthases and their mutants.
  • Grand fir has been developed as a model system to study the biochemical and molecular genetic regulation of constitutive and inducible terpene biosynthesis in conifers (Steele, C, Lewinsohn, E., and Croteau, R. (1995) Proc. Nail Acad. Sci. USA 92:4164-4168).
  • Acyclic monoterpenes such as myrcene
  • myrcene may arise by deprotonation of carbocations 1 or 2
  • the isomerization step to linalyl diphosphate is required in the case of cyclic types, such as limonene and pinenes, which cannot be derived from geranyl diphosphate directly because of the geometric impediment of the tr ⁇ s-double bond at C2-C3 (Croteau, R., and Cane, D.E. (1985) Methods Enzymol 110:383-405; Croteau, R. (1987) Chem. Rev. 87:929-954).
  • (-)-limonene synthase the principal monoterpene synthase of spearmint (Mentha spicata) and peppermint (M. x piperita) produces small amounts of myrcene, (-)- ⁇ -pinene and (-)- ⁇ -pinene in addition to the monocyclic product (Rajaonarivony, J.I.M., Gershenzon, J., and Croteau, R. (1992) Arch. Biochem. Biophys. 296:49-57; Colby, S.M., Alonso, W.R., Katahira, E.J., McGarvey, D.J.. and Croteau, R. (1993) J. Biol.
  • Monoterpenes have significant potential for cancer prevention and treatment.
  • Monoterpenes such as limonene, perillyl alcohol, carvone, geraniol and farnesol not only reduce tumor incidence and slow tumor proliferation, but have also been reported to cause regression of established solid tumors by initiating apoptosis (Mills J.J., Chari R.S., Boyer I.J., Gould M.N., Jirtle R.L., Cancer Res., 55:979-983, 1995).
  • Terpenes have activity against cancers such as mammary, colon, and prostate. Clinical trials are being pursued (Seachrist L, J. NIH Res.
  • terpenes are present in Western diets at levels that are probably inadequate for any significant preventive health benefits.
  • Daily supplementation of the diet with a terpene concentrate (10-20 g/day) would appear to be the most rational strategy for dietary therapy of diagnosed cases of cancer.
  • This invention envisages the production of such nutritionally beneficial terpenes in vegetable oils consumed daily via the engineering of relevant genes from Grand fir into oil seed crop plants such as oil seed brassica (canola), soybean and corn.
  • FIGURE 1 is a schematic representation depicting the mechanism for the conversion of geranyl diphosphate to myrcene, (-)-limonene, ⁇ -phellandrene,
  • FIGURE 2 is a sequence comparison of plant terpene synthases.
  • Tps three- letter designation
  • Tpsa through Tpsf sub-groups
  • FIGURE 3 depicts a GLC-MS analysis of the products of the recombinant protein encoded by AG2.2 (SEQ ID NO:l), the sequence of the protein encoded by clone AG2.2 being set forth in SEQ ID NO:2.
  • FIGURE 4 depicts a GLC-MS analysis of the products of the recombinant protein encoded by AG3.18 (SEQ ID NO:3), the sequence of the protein encoded by clone AG3.18 (SEQ ID NO:3) being set forth in SEQ ID NO:4.
  • FIGURE 5 depicts a GLC-MS analysis of the products of the recombinant protein encoded by AGIO (SEQ ID NO:5), the sequence of the protein encoded by clone AGIO (SEQ ID NO:5) being set forth in SEQ ID NO:6.
  • the present invention relates to isolated DNA sequences which code for the expression of myrcene synthase, such as the sequence designated SEQ ID NO:l which encodes myrcene synthase from Grand fir (Abies grandis), for the expression of (-)-pinene synthase, such as the sequence designated SEQ ID NO:3, which encodes the (-)-pinene synthase from Grand fir (Abies grandis) and for the expression of (-)-limonene synthase, such as the sequence designated SEQ ID NO:5, which encodes (-)-limonene synthase from Grand fir (Abies grandis).
  • SEQ ID NO:l which encodes myrcene synthase from Grand fir (Abies grandis)
  • SEQ ID NO:3 which encodes the (-)-pinene synthase from Grand fir (Abies grandis)
  • SEQ ID NO:5 which encodes (-)-limonene synthase from Grand
  • the present invention is directed to replicable recombinant cloning vehicles comprising a nucleic acid sequence, e.g., a DNA sequence which codes for a myrcene synthase, (-)-limonene synthase or (-)-pinene synthase, or for a base sequence sufficiently complementary to at least a portion of DNA or RNA encoding myrcene synthase, (-)-limonene synthase or (-)-pinene synthase to enable hybridization therewith (e.g., antisense RNA or fragments of DNA complementary to a portion of DNA or RNA molecules encoding myrcene synthase, (-)-limonene synthase or (-)-pinene synthase which are useful as polymerase chain reaction primers or as probes for any of the foregoing synthases or related genes).
  • a nucleic acid sequence e.g., a DNA sequence which codes
  • modified host cells are provided that have been transformed, transfected, infected and/or injected with a recombinant cloning vehicle and/or DNA sequence of the invention.
  • the present invention provides for the recombinant expression of myrcene synthase, (-)-limonene synthase and (-)-pinene synthase, and the inventive concepts may be used to facilitate the production, isolation and purification of significant quantities of recombinant myrcene synthase, (-)-limonene synthase and (-)-pinene synthase (or of their primary enzyme products) for subsequent use, to obtain expression or enhanced expression of myrcene synthase, (-)-limonene synthase and (-)-pinene synthase in plants, microorganisms or animals, or may be otherwise employed in an environment where the regulation or expression of myrcene synthase, (-)-lim ⁇
  • amino acid and “amino acids” refer to all naturally occurring L- ⁇ -amino acids or their residues.
  • the amino acids are identified by either the single-letter or three-letter designations:
  • nucleotide means a monomeric unit of DNA or RNA containing a sugar moiety (pentose), a phosphate and a nitrogenous heterocyclic base.
  • the base is linked to the sugar moiety via the glycosidic carbon (V carbon of pentose) and that combination of base and sugar is called a nucleoside.
  • the base characterizes the nucleotide with the four bases of DNA being adenine ("A”), guanine (“G”), cytosine (“C”) and thymine (“T”).
  • Inosine is a synthetic base that can be used to substitute for any of the four, naturally-occurring bases (A, C, G or T).
  • RNA bases are A,G,C and uracil ("U").
  • the nucleotide sequences described herein comprise a linear array of nucleotides connected by phosphodiester bonds between the 3' and 5' carbons of adjacent pentoses.
  • percent identity means the percentage of amino acids or nucleotides that occupy the same relative position when two amino acid sequences, or two nucleic acid sequences are aligned side by side.
  • percent similarity is a statistical measure of the degree of relatedness of two compared protein sequences.
  • the percent similarity is calculated by a computer program that assigns a numerical value to each compared pair of amino acids based on chemical similarity (e.g., whether the compared amino acids are acidic, basic, hydrophobic, aromatic, etc.) and/or evolutionary distance as measured by the minimum number of base pair changes that would be required to convert a codon encoding one member of a pair of compared amino acids to a codon encoding the other member of the pair. Calculations are made after a best fit alignment of the two sequences have been made empirically by iterative comparison of all possible alignments. (Henikoff, S. and Henikoff, J.G., Proc. Nat'l. Acad. Sci.
  • Oligonucleotide refers to short length single or double stranded sequences of deoxyribonucleotides linked via phosphodiester bonds.
  • the oligonucleotides are chemically synthesized by known methods and purified, for example, on polyacrylamide gels.
  • myrcene synthase is used herein to mean an enzyme capable of generating multiple monoterpenes from geranyl diphosphate.
  • the principal and characteristic monoterpene synthesized by myrcene synthase is myrcene, which constitutes at least about 60% of the monoterpene mixture synthesized by myrcene synthase from geranyl diphosphate.
  • (-)-limonene synthase is used herein to mean an enzyme capable of generating multiple monoterpenes from geranyl diphosphate.
  • the principal and characteristic monoterpene synthesized by (-)-limonene synthase is (-)-limonene, which constitutes at least about 60% of the monoterpene mixture synthesized by (-)-limonene synthase from geranyl diphosphate.
  • (-)-pinene synthase is used herein to mean an enzyme capable of generating multiple monoterpenes from geranyl diphosphate.
  • the principal and characteristic monoterpene synthesized by (-)-pinene synthase is (-)-pinene, which comprises at least about 60% of the monoterpene mixture synthesized by (-)-pinene synthase from geranyl diphosphate.
  • SSPE refers to a buffer used in nucleic acid hybridization solutions.
  • the 20X (twenty times concentrate) stock SSPE buffer solution is prepared as follows: dissolve 175.3 grams of NaCl, 27.6 grams of NaH 2 PO 4 H 2 O and
  • alteration refers to monoterpene synthase molecules with some differences in their amino acid sequences as compared to the corresponding, native, i.e., naturally-occurring, monoterpene synthases.
  • the variants will possess at least about 70% homology with the corresponding native monoterpene synthases, and preferably, they will be at least about 80% homologous with the corresponding, native monoterpene synthases.
  • the amino acid sequence variants of the monoterpene synthases falling within this invention possess substitutions, deletions, and/or insertions at certain positions. Sequence variants of monoterpene synthases may be used to attain desired enhanced or reduced enzymatic activity, modified regiochemistry or stereochemistry, or altered substrate utilization or product distribution.
  • Substitutional monoterpene synthase variants are those that have at least one amino acid residue in the native monoterpene synthase sequence removed and a different amino acid inserted in its place at the same position.
  • the substitutions may be single, where only one amino acid in the molecule has been substituted, or they may be multiple, where two or more amino acids have been substituted in the same molecule.
  • Substantial changes in the activity of the monoterpene synthase molecules of the present invention may be obtained by substituting an amino acid with a side chain that is significantly different in charge and/or structure from that of the native amino acid. This type of substitution would be expected to affect the structure of the polypeptide backbone and/or the charge or hydrophobicity of the molecule in the area of the substitution.
  • Moderate changes in the activity of the monoterpene synthase molecules of the present invention would be expected by substituting an amino acid with a side chain that is similar in charge and/or structure to that of the native molecule.
  • This type of substitution referred to as a conservative substitution, would not be expected t ⁇ substantially alter either the structure of the polypeptide backbone or the charge or hydrophobicity of the molecule in the area of the substitution.
  • Insertional monoterpene synthase variants are those with one or more amino acids inserted immediately adjacent to an amino acid at a particular position in the native monoterpene synthase molecule. Immediately adjacent to an amino acid means connected to either the ⁇ -carboxy or -amino functional group of the amino acid.
  • the insertion may be one or more amino acids.
  • the insertion will consist of one or two conservative amino acids. Amino acids similar in charge and/or structure to the amino acids adjacent to the site of insertion are defined as conservative.
  • this invention includes insertion of an amino acid with a charge and/or structure that is substantially different from the amino acids adjacent to the site of insertion.
  • Deletional variants are those where one or more amino acids in the native monoterpene synthase molecules have been removed. Ordinarily, deletional variants will have one or two amino acids deleted in a particular region of the monoterpene synthase molecule.
  • biological activity refers to the ability of the monoterpene synthases of the present invention to convert geranyl diphosphate to a group of monoterpenes, of which myrcene is the principal and characteristic monoterpene synthesized by myrcene synthase, (-)-limonene is the principal and characteristic monoterpene synthesized by (-)-limonene synthase and (-)-pinene is the principal and characteristic monoterpene synthesized by (-)-pinene synthase.
  • the monoterpenes produced by the monoterpene synthases of the present invention are as measured in an enzyme activity assay, such as the assay described in Example 3.
  • Amino acid sequence variants of the terpene synthases of the present invention may have desirable altered biological activity including, for example, altered reaction kinetics, substrate utilization product distribution or other characteristics such as regiochemistry and stereochemistry.
  • DNA sequence encoding refers to the order or sequence of deoxyribonucleotides along a strand of deoxyribonucleic acid. The order of these deoxyribonucleotides determines the order of amino acids along the translated polypeptide chain. The DNA sequence thus codes for the amino acid sequence.
  • replicable expression vector and "expression vector” refer to a piece of DNA, usually double-stranded, which may have inserted into it a piece of foreign DNA.
  • Foreign DNA is defined as heterologous DNA, which is DNA not naturally found in the host.
  • the vector is used to transport the foreign or heterologous DNA into a suitable host cell. Once in the host cell, the vector can replicate independently of or coincidental with the host chromosomal DNA, and several copies of the vector and its inserted (foreign) DNA may be generated.
  • the vector contains the necessary elements that permit translating the foreign DNA into a polypeptide. Many molecules of the polypeptide encoded by the foreign DNA can thus be rapidly synthesized.
  • transformed host cell refers to the introduction of DNA into a cell.
  • the cell is termed a "host cell”, and it may be a prokaryotic or a eukaryotic cell.
  • Typical prokaryotic host cells include various strains of E. coli.
  • Typical eukaryotic host cells are plant cells, such as maize cells, yeast cells, insect cells or animal cells.
  • the introduced DNA is usually in the form of a vector containing an inserted piece of DNA.
  • the introduced DNA sequence may be from the same species as the host cell or from a different species from the host cell, or it may be a hybrid DNA sequence, containing some foreign DNA and some DNA derived from the host species.
  • abbreviations are used herein: bp(s), base pair(s); DEAE,
  • cDNAs encoding myrcene synthase (SEQ ID NO:l), (-)-pinene synthase (SEQ ID NO:3) and (-)-limonene synthase (SEQ ID NO:5) from Grand fir (Abies grandis) were isolated and sequenced in the following manner. Based on comparison of sequences of limonene synthase from spearmint (Colby, S.M., Alonso, W.R., Katahira, E.J., McGarvey, D.J., and Croteau, R. (1993) J. Biol Chem.
  • Primer A SEQ ID NO:7
  • Primer B SEQ ID NO:8
  • Primer C SEQ ID NO:9
  • Primer D SEQ ID NO: 10
  • the 1 10 bps PCR product was gel purified, ligated into a plasmid, and transformed into E. coli XL 1 -Blue cells. Plasmid DNA was prepared from 41 individual transformants and the inserts were sequenced. Four different insert sequences were identified, and were designated as probes 1 (SEQ ID NO:l 1), 2 (SEQ ID NO: 12), 4 (SEQ ID NO:13) and 5 (SEQ ID NO: 14).
  • Probes 1 SEQ ID NO: 11
  • 2 SEQ ID NO:12
  • 4 SEQ ID NO:13
  • 5 SEQ ID NO:14
  • clone AG1.28 (SEQ ID NO: 15) is the longest cDNA clone that hybridized to probe 1 (SEQ ID NO:l l)
  • clone AG2.2 (SEQ ID NO:l) is the longest cDNA clone that hybridized to probe 2 (SEQ ID NO: 12)
  • clone AG4.30 (SEQ ID NO: 17) is the longest cDNA clone that hybridized to probe 4 (SEQ ID NO: 13)
  • clone AG5.9 (SEQ ID NO: 19) is the longest cDNA clone that hybridized to probe 5 (SEQ ID NO: 14).
  • Truncated clone AG1.28 (SEQ ID NO:15) resembled most closely in size and sequence (72% similarity, 49% identity) a diterpene cyclase, abietadiene synthase, from Grand fir.
  • Clones AG4.30 (SEQ ID NO: 17) and AG5.9 (SEQ ID NO: 19) encode sesquiterpene synthases.
  • Sequence and functional analysis of clone AG2.2 revealed that it encoded the monoterpene synthase, myrcene synthase.
  • Probe 3 (SEQ ID NO:24) was used to screen a cDNA library made from mRNA extracted from wounded Grand fir stems. Hybridization of 10 Grand fir ⁇ ZAP II cDNA clones with probe 3 (SEQ ID NO:24) yielded two types of signals comprised of about 400 strongly positive clones and an equal number of weak positives, indicating that the probe recognized more than one type of cDNA. Thirty- four of the former clones and eighteen of the latter were purified, the inserts were selected by size (2.0-2.5 kb), and the in vivo excised clones were partially sequenced from both ends.
  • the isolation of the (-)-limonene synthase, (-)-pinene synthase and myrcene synthase cDNAs also permits the transformation of a wide range of organisms in order to introduce monoterpene biosynthesis de novo, or to modify endogenous monoterpene biosynthesis.
  • sequence variants produced by deletions, substitutions, mutations and/or insertions are intended to be within the scope of the invention except insofar as limited by the prior art.
  • the (-)-limonene synthase, (-)-pinene synthase and myrcene synthase amino acid sequence variants of this invention may be constructed by mutating the DNA sequences that encode the wild-type synthases, such as by using techniques commonly referred to as site-directed mutagenesis.
  • Nucleic acid molecules encoding the monoterpene synthases of the present invention can be mutated by a variety of PCR techniques well known to one of ordinary skill in the art. See, e.g., "PCR Strategies", M.A. Innis, D.H. Gelfand and J.J. Sninsky, eds., 1995, Academic Press, San Diego, CA (Chapter 14); “PCR Protocols: A Guide to Methods and Applications", M.A. Innis, D.H. Gelfand, J.J. Sninsky and T.J. White, eds., Academic Press, NY ( 1990).
  • the two primer system utilized in the Transformer Site-Directed Mutagenesis kit from Clontech may be employed for introducing site-directed mutants into the monoterpene synthase genes of the present invention.
  • two primers are simultaneously annealed to the plasmid; one of these primers contains the desired site-directed mutation, the other contains a mutation al another point in the plasmid resulting in elimination of a restriction site.
  • Second strand synthesis is then carried out, lightly linking these two mutations, and the resulting plasmids are transformed into a mutS strain of E. coli.
  • Plasmid DNA is isolated from the transformed bacteria, restricted with the relevant restriction enzyme (thereby linearizing the unmutated plasmids), and then retransformed into E. coli.
  • This system allows for generation of mutations directly in an expression plasmid, without the necessity of subcloning or generation of single-stranded phagemids.
  • the tight linkage of the two mutations and the subsequent linearization of unmutated plasmids results in high mutation efficiency and allows minimal screening. Following synthesis of the initial restriction site primer, this method requires the use of only one new primer type per mutation site.
  • a set of "designed degenerate" oligonucleotide primers can be synthesized in order to introduce all of the desired mutations at a given site simultaneously.
  • Transformants can be screened by sequencing the plasmid DNA through the mutagenized region to identify and sort mutant clones. Each mutant DNA can then be restricted and analyzed by electrophoresis on Mutation Detection Enhancement gel (J.T. Baker) to confirm that no other alterations in the sequence have occurred (by band shift comparison to the unmutagenized control).
  • the verified mutant duplexes in the pET (or other) overexpression vector can be employed to transform E. coli such as strain E.
  • coli BL21(DE3)pLysS for high level production of the mutant protein, and purification by standard protocols.
  • the method of FAB-MS mapping can be employed to rapidly check the fidelity of mutant expression. This technique provides for sequencing segments throughout the whole protein and provides the necessary confidence in the sequence assignment.
  • protein is digested with a protease (the choice will depend on the specific region to be modified since this segment is of prime interest and the remaining map should be identical to the map of unmutagenized protein).
  • the set of cleavage fragments is fractionated by microbore HPLC (reversed phase or ion exchange, again depending on the specific region to be modified) to provide several peptides in each fraction, and the molecular weights of the peptides are determined by FAB-MS.
  • the masses are then compared to the molecular weights of peptides expected from the digestion of the predicted sequence, and the correctness of the sequence quickly ascertained. Since this mutagenesis approach to protein modification is directed, sequencing of the altered peptide should not be necessary if the MS agrees with prediction.
  • CAD-tandem MS/MS can be employed to sequence the peptides of the mixture in question, or the target peptide purified for subtractive Edman degradation or carboxypeptidase Y digestion depending on the location of the modification.
  • a non-conservative substitution e.g., Ala for Cys, His or Glu
  • the properties of the mutagenized protein are then examined with particular attention to the kinetic parameters of K m and k cat as sensitive indicators of altered function, from which changes in binding and/or catalysis per se may be deduced by comparison to the native enzyme.
  • restriction endonuclease digestion of DNA followed by ligation may be used to generate deletion variants of (-)-limonene synthase, (-)-pinene synthase and myrcene synthase, as described in section 15.3 of Sambrook et al. (Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory Press, New York, NY [1989]).
  • a similar strategy may be used to construct insertion variants, as described in section 15.3 of Sambrook et al., supra.
  • Oligonucleotide-directed mutagenesis may also be employed for preparing substitution variants of this invention. It may also be used to conveniently prepare the deletion and insertion variants of this invention.
  • This technique is well known in the art as described by Adelman et al. (DNA 2: 183 [1983]); Sambrook et al., supra; "Current Protocols in Molecular Biology", 1991, Wiley (NY), F.T. Ausubel, R. Brent, R.E. Scientific, D.D. Moore, J.D. Seidman, J.A. Smith and K. Struhl, eds.
  • oligonucleotides of at least 25 nucleotides in length are used to insert, delete or substitute two or more nucleotides in the (-)-limonene synthase, (-)-pinene synthase and myrcene synthase molecule.
  • An optimal oligonucleotide will have 12 to 15 perfectly matched nucleotides on either side of the nucleotides coding for the mutation.
  • the oligonucleotide is annealed to the single-stranded DNA template molecule under suitable hybridization conditions.
  • a DNA polymerizing enzyme usually the Klenow fragment of E. coli DNA polymerase I, is then added.
  • This enzyme uses the oligonucleotide as a primer to complete the synthesis of the mutation-bearing strand of DNA.
  • a heteroduplex molecule is formed such that one strand of DNA encodes the wild-type synthase inserted in the vector, and the second strand of DNA encodes the mutated form of the synthase inserted into the same vector.
  • This heteroduplex molecule is then transformed into a suitable host cell.
  • Mutants with more than one amino acid substituted may be generated in one of several ways. If the amino acids are located close together in the polypeptide chain, they may be mutated simultaneously using one oligonucleotide that codes for all of the desired amino acid substitutions. If however, the amino acids are located some distance from each other (separated by more than ten amino acids, for example) it is more difficult to generate a single oligonucleotide that encodes all of the desired changes. Instead, one of two alternative methods may be employed. In the first method, a separate oligonucleotide is generated for each amino acid to be substituted.
  • the oligonucleotides are then annealed to the single-stranded template DNA simultaneously, and the second strand of DNA that is synthesized from the template will encode all of the desired amino acid substitutions.
  • An alternative method involves two or more rounds of mutagenesis to produce the desired mutant. The first round is as described for the single mutants: wild-type (-)-limonene synthase, (-)-pinene synthase and myrcene synthase DNA is used for the template, an oligonucleotide encoding the first desired amino acid substitution(s) is annealed to this template, and the heteroduplex DNA molecule is then generated.
  • the second round of mutagenesis utilizes the mutated DNA produced in the first round of mutagenesis as the template.
  • this template already contains one or more mutations.
  • the oligonucleotide encoding the additional desired amino acid substitution(s) is then annealed to this template, and the resulting strand of DNA now encodes mutations from both the first and second rounds of mutagenesis.
  • This resultant DNA can be used as a template in a third round of mutagenesis, and so on.
  • a gene encoding (-)-limonene synthase, (-)-pinene synthase and myrcene synthase may be incorporated into any organism (intact plant, animal, microbe, etc.), or cell culture derived therefrom, that produces geranyl diphosphate.
  • a (-)-limonene synthase, (-)-pinene synthase and myrcene synthase gene may be introduced into any organism for a variety of purposes including, but not limited to: production of (-)-limonene synthase, (-)-pinene synthase and myrcene synthase, or their products; production or modification of flavor and aroma properties; improvement of defense capability, and the alteration of other ecological interactions mediated by myrcene, (-)-limonene, (-)-pinene, or their derivatives.
  • Eukaryotic expression systems may be utilized for the production of (-)-limonene synthase, (-)-pinene synthase and myrcene synthase since they are capable of carrying out any required posttranslational modifications and of directing the enzymes to the proper membrane location.
  • a representative eukaryotic expression system for this purpose uses the recombinant baculovirus, Autographa califomica nuclear polyhedrosis virus (AcNPV; M.D. Summers and G.E.
  • baculoviruses do not infect humans and can therefore be safely handled in large quantities.
  • a DNA construct is prepared including a DNA segment encoding (-)-limonene synthase, (-)-pinene synthase and myrcene synthase and a vector.
  • the vector may comprise the polyhedron gene promoter region of a baculovirus, the baculovirus flanking sequences necessary for proper cross-over during recombination (the flanking sequences comprise about 200-300 base pairs adjacent to the promoter sequence) and a bacterial origin of replication which permits the construct to replicate in bacteria.
  • the vector is constructed so that (i) the DNA segment is placed adjacent (or operably linked or "downstream” or “under the control of”) to the polyhedron gene promoter and (ii) the promoter/monoterpene synthase combination is flanked on both sides by 200-300 base pairs of baculovirus DNA (the flanking sequences).
  • a cDNA clone encoding the full length (-)-limonene synthase, (-)-pinene synthase and myrcene synthase is obtained using methods such as those described herein.
  • the DNA construct is contacted in a host cell with baculovirus DNA of an appropriate baculovirus (that is, of the same species of baculovirus as the promoter encoded in the construct) under conditions such that recombination is effected.
  • the resulting recombinant baculoviruses encode the full (-)-limonene synthase, (-)-pinene synthase and myrcene synthase.
  • an insect host cell can be cotransfected or transfected separately with the DNA construct and a functional baculovirus. Resulting recombinant baculoviruses can then be isolated and used to infect cells to effect production of the monoterpene synthase.
  • Host insect cells include, for example, Spodoptera frugiperda cells, that are capable of producing a baculovirus- expressed monoterpene synthase.
  • Insect host cells infected with a recombinant baculovirus of the present invention are then cultured under conditions allowing expression of the baculovirus-encoded (-)-limonene synthase, (-)-pinene synthase and myrcene synthase.
  • (-)-limonene synthase, (-)-pinene synthase and myrcene synthase are then extracted from the cells using methods known in the art.
  • yeasts may also be used to practice this invention.
  • the baker's yeast Saccharomyces cerevisiae is a commonly used yeast, although several other strains are available.
  • the plasmid YRp7 (Stinchcomb et al., Nature 282:39 [1979J; Kingsman et al., Gene 7:141 [1979]; Tschemper et al., Gene 10:157 [1980]) is commonly used as an expression vector in Saccharomyces.
  • This plasmid contains the trpl gene that provides a selection marker for a mutant strain of yeast lacking the ability to grow in tryptophan, such as strains ATCC No.
  • yeast host cells are generally transformed using the polyethylene glycol method, as described by Hinnen (Proc. Natl. Acad. Sci. USA 75: 1929 [1978]). Additional yeast transformation protocols are set forth in Gietz et al., N.A. R. 20(17) 1425(1992); Reeves et al., FEMS 99(2-3): 193-197, (1992). Suitable promoting sequences in yeast vectors include the promoters for
  • the termination sequences associated with these genes are also ligated into the expression vector 3' of the sequence desired to be expressed to provide polyadenylation of the mRNA and termination.
  • Other promoters that have the additional advantage of transcription controlled by growth conditions are the promoter region for alcohol dehydrogenase 2, isocytochrome C, acid phosphatase, degradative enzymes associated with nitrogen metabolism, and the aforementioned glyceraldehyde-3-phosphate dehydrogenase, and enzymes responsible for maltose and galactose utilization.
  • Any plasmid vector containing yeast-compatible promoter, origin of replication and termination sequences is suitable.
  • Transgenic plants can be obtained, for example, by transferring plasmids that encode (-)-limonene synthase, (-)-pinene synthase and myrcene synthase and a selectable marker gene, e.g., the kan gene encoding resistance to kanamycin, into Agrobacterium lumifaciens containing a helper Ti plasmid as described in Hoeckema et al., Nature 303:179-181 [1983] and culturing the Agrobacterium cells with leaf slices of the plant to be transformed as described by An et al., Plant Physiology 81:301-305 [1986].
  • a selectable marker gene e.g., the kan gene encoding resistance to kanamycin
  • Transformation of cultured plant host cells is normally accomplished through Agrobacterium lumifaciens, as described above.
  • Cultures of mammalian host cells and other host cells that do not have rigid cell membrane barriers are usually transformed using the calcium phosphate method as originally described by Graham and Van der Eb (Virology 52:546 [1978]) and modified as described in sections 16.32-16.37 of Sambrook et al., supra.
  • other methods for introducing DNA into cells such as Polybrene (Kawai and Nishizawa, Mol. Cell. Biol. 4: 1172 [1984]), protoplast fusion (Schaffner, Proc. Nail. Acad. Sci. USA 77:2163 [1980]), electroporation (Neumann et al., EMBOJ.
  • Transformed plant calli may be selected through the selectable marker by growing the cells on a medium containing, e.g., kanamycin, and appropriate amounts of phytohormone such as naphthalene acetic acid and benzyladenine for callus and shoot induction. The plant cells may then be regenerated and the resulting plants transferred to soil using techniques well known to those skilled in the art.
  • a gene regulating (-)-limonene synthase, (-)-pinene synthase and myrcene synthase production can be incorporated into the plant along with a necessary promoter which is inducible.
  • a promoter that only responds to a specific external or internal stimulus is fused to the target cDNA.
  • the gene will not be transcribed except in response to the specific stimulus. As long as the gene is not being transcribed, its gene product is not produced.
  • GSTs are a family of enzymes that can detoxify a number of hydrophobic electrophilic compounds that often are used as pre-emergent herbicides (Weigand et al., Plant Molecular Biology 7:235-243 [1986]). Studies have shown that the GSTs are directly involved in causing this enhanced herbicide tolerance. This action is primarily mediated through a specific 1.1 kb mRNA transcription product. In short, maize has a naturally occurring quiescent gene already present that can respond to external stimuli and that can be induced to produce a gene product.
  • the promoter is removed from the GST responsive gene and attached to a (-)-limonene synthase, (-)-pinene synthase and myrcene synthase gene that previously has had its native promoter removed.
  • This engineered gene is the combination of a promoter that responds to an external chemical stimulus and a gene responsible for successful production of (-)-limonene synthase, (-)-pinene synthase and myrcene synthase.
  • DNA from a plasmid is genetically engineered such that it contains not only the gene of interest, but also selectable and screenable marker genes.
  • a selectable marker gene is used to select only those cells that have integrated copies of the plasmid (the construction is such that the gene of interest and the selectable and screenable genes are transferred as a unit).
  • the screenable gene provides another check for the successful culturing of only those cells carrying the genes of interest.
  • a commonly used selectable marker gene is neomycin phosphotransferase II (NPT II). This gene conveys resistance to kanamycin, a compound that can be added directly to the growth media on which the cells grow.
  • Plant cells are normally susceptible to kanamycin and, as a result, die.
  • the presence of the NPT II gene overcomes the effects of the kanamycin and each cell with this gene remains viable.
  • Another selectable marker gene which can be employed in the practice of this invention is the gene which confers resistance to the herbicide glufosinate (Basta).
  • a screenable gene commonly used is the ⁇ -glucuronidase gene (GUS). The presence of this gene is characterized using a histochemical reaction in which a sample of putatively transformed cells is treated with a GUS assay solution. After an appropriate incubation, the cells containing the GUS gene turn blue.
  • the plasmid containing one or more of these genes is introduced into either plant protoplasts or callus cells by any of the previously mentioned techniques. If the marker gene is a selectable gene, only those cells that have incorporated the DNA package survive under selection with the appropriate phytotoxic agent. Once the appropriate cells are identified and propagated, plants are regenerated. Progeny from the transformed plants must be tested to insure that the DNA package has been successfully integrated into the plant genome.
  • Mammalian host cells may also be used in the practice of the invention.
  • suitable mammalian cell lines include monkey kidney CVI line transformed by SV40 (COS-7, ATCC CRL 1651); human embryonic kidney Hne 293S (Graham et al., J. Gen. Virol. 36:59 [1977]); baby hamster kidney cells (BHK, ATCC CCL 10); Chinese hamster ovary cells (Urlab and Chasin, Proc. Natl. Acad. Sci USA 77:4216 [1980]); mouse sertoli cells (TM4, Mather, Biol. Reprod.
  • monkey kidney cells CVI-76, ATCC CCL 70); African green monkey kidney cells (VERO-76, ATCC CRL- 1587); human cervical carcinoma cells (HELA, ATCC CCL 2); canine kidney cells (MDCK, ATCC CCL 34); buffalo rat liver cells (BRL 3 A, ATCC CRL 1442); human lung cells (W138, ATCC CCL 75); human liver cells (Hep G2, HB 8065); mouse mammary tumor cells (MMT 060562, ATCC CCL 51); rat hepatoma cells (HTC, MI.54, Baumann et al., J. Cell Biol 85: 1 [1980]); and TRI cells (Mather et al., Annals N. Y.
  • Expression vectors for these cells ordinarily include (if necessary) DNA sequences for an origin of replication, a promoter located in front of the gene to be expressed, a ribosome binding site, an RNA splice site, a polyadenylation site, and a transcription terminator site.
  • Promoters used in mammalian expression vectors are often of viral origin. These viral promoters are commonly derived from polyoma virus, Adenovirus 2, and most frequently Simian Virus 40 (SV40).
  • the SV40 virus contains two promoters that are termed the early and late promoters. These promoters are particularly useful because they are both easily obtained from the virus as one DNA fragment that also contains the viral origin of replication (Fiers et al, Nature 273:113 [1978]). Smaller or larger SV40 DNA fragments may also be used, provided they contain the approximately 250-bp sequence extending from the Hindlll site toward the Bgll site located in the viral origin of replication. Alternatively, promoters that are naturally associated with the foreign gene
  • homologous promoters may be used provided that they are compatible with the host cell line selected for transformation.
  • An origin of replication may be obtained from an exogenous source, such as
  • the origin of replication may be provided by the host cell chromosomal replication mechanism. If the vector containing the foreign gene is integrated into the host cell chromosome, the latter is often sufficient.
  • the use of a secondary DNA coding sequence can enhance production levels of (-)-limonene synthase, (-)-pinene synthase and myrcene synthase in transformed cell lines.
  • the secondary coding sequence typically comprises the enzyme dihydrofolate reductase (DHFR).
  • DHFR dihydrofolate reductase
  • the wild-type form of DHFR is normally inhibited by the chemical methotrexate (MTX).
  • MTX chemical methotrexate
  • the level of DHFR expression in a cell will vary depending on the amount of MTX added to the cultured host cells.
  • An additional feature of DHFR that makes it particularly useful as a secondary sequence is that it can be used as a selection marker to identify transformed cells.
  • DHFR-deficient cell lines such as the CHO cell line described by Urlaub and Chasin, supra, are transformed with wild-type DHFR coding sequences. After transformation, these DHFR-deficient cell lines express functional DHFR and are capable of growing in a culture medium lacking the nutrients hypoxanthine, glycine and thymidine. Nontransformed cells will not survive in this medium.
  • the MTX-resistant form of DHFR can be used as a means of selecting for transformed host cells in those host cells that endogenously produce normal amounts of functional DHFR that is MTX sensitive.
  • the CHO-K1 cell line (ATCC No. CL 61) possesses these characteristics, and is thus a useful cell line for this purpose.
  • the addition of MTX to the cell culture medium will permit only those cells transformed with the DNA encoding the MTX-resistant DHFR to grow. The nontransformed cells will be unable to survive in this medium.
  • Prokaryotes may also be used as host cells for the initial cloning steps of this invention. They are particularly useful for rapid production of large amounts of DNA, for production of single-stranded DNA templates used for site-directed mutagenesis, for screening many mutants simultaneously, and for DNA sequencing of the mutants generated.
  • Suitable prokaryotic host cells include E. coli K12 strain 94 (ATCC No. 31,446), E. coli strain W3110 (ATCC No. 27,325) E. coli X1776 (ATCC No. 31 ,537), and E. coli B; however many other strains of E.
  • coli such as HB101, JM101, NM522, NM538, NM539, and many other species and genera of prokaryotes including bacilli such as Bacillus subtilis, other enterobacteriaceae such as Salmonella typhimurium or Serratia marcesans, and various Pseudomonas species may all be used as hosts.
  • Prokaryotic host cells or other host cells with rigid cell walls are preferably transformed using the calcium chloride method as described in section 1.82 of Sambrook et al., supra. Alternatively, electroporation may be used for transformation of these cells.
  • cDNA sequences encoding (-)-limonene synthase, (-)-pinene synthase or myrcene synthase may be transferred to the (His)6*Tag pET vector commercially available (from Novagen) for overexpression in E. coli as heterologous host.
  • This pET expression plasmid has several advantages in high level heterologous expression systems.
  • the desired cDNA insert is ligated in frame to plasmid vector sequences encoding six histidines followed by a highly specific protease recognition site (thrombin) that are joined to the amino terminus codon of the target protein.
  • the histidine "block" of the expressed fusion protein promotes very tight binding to immobilized metal ions and permits rapid purification of the recombinant protein by immobilized metal ion affinity chromatography.
  • the histidine leader sequence is then cleaved at the specific proteolysis site by treatment of the purified protein with thrombin, and the (-)-limonene synthase, (-)-pinene synthase and myrcene synthase again purified by immobilized metal ion affinity chromatography, this time using a shallower imidazole gradient to elute the recombinant synthases while leaving the histidine block still adsorbed.
  • This overexpression-purification system has high capacity, excellent resolving power and is fast, and the chance of a contaminating E. coli protein exhibiting similar binding behavior (before and after thrombin proteolysis) is extremely small.
  • any plasmid vectors containing replicon and control sequences that are derived from species compatible with the host cell may also be used in the practice of the invention.
  • the vector usually has a replication site, marker genes that provide phenotypic selection in transformed cells, one or more promoters, and a polylinker region containing several restriction sites for insertion of foreign DNA.
  • Plasmids typically used for transformation of E. coli include pBR322, pUC18, pUC19, pUCI18, pUC119, and Bluescript M13, all of which are described in sections 1.12-1.20 of Sambrook et al., supra. However, many other suitable vectors are available as well. These vectors contain genes coding for ampicillin and/or tetracycline resistance which enables cells transformed with these vectors to grow in the presence of these antibiotics.
  • the promoters most commonly used in prokaryotic vectors include the ⁇ -lactamase (penicillinase) and lactose promoter systems (Chang et al. Nature 375:615 [1978]; Itakura et al., Science 198:1056 [1977]; Goeddel et al., Nature 281:544 [1979]) and a tryptophan (trp) promoter system (Goeddel et al., Nucl. Acids Res. 8:4057 [1980]; EPO Appl. Publ. No. 36,776), and the alkaline phosphatase systems.
  • proteins normally secreted from the cell contain an endogenous secretion signal sequence as part of the amino acid sequence.
  • proteins normally found in the cytoplasm can be targeted for secretion by linking a signal sequence to the protein. This is readily accomplished by ligating DNA encoding a signal sequence to the 5' end of the DNA encoding the protein and then expressing this fusion protein in an appropriate host cell.
  • the DNA encoding the signal sequence may be obtained as a restriction fragment from any gene encoding a protein with a signal sequence.
  • prokaryotic, yeast, and eukaryotic signal sequences may be used herein, depending on the type of host cell utilized to practice the invention.
  • the DNA and amino acid sequence encoding the signal sequence portion of several eukaryotic genes including, for example, human growth hormone, proinsulin, and proalbumin are known (see Stryer, Biochemistry W.H. Freeman and Company, New York, NY, p. 769 [1988]), and can be used as signal sequences in appropriate eukaryotic host cells.
  • Yeast signal sequences as for example acid phosphatase (Arima et al., Nuc. Acids Res. 11:1657 [1983]), ⁇ -factor, alkaline phosphatase and invertase may be used to direct secretion from yeast host cells.
  • Prokaryotic signal sequences from genes encoding, for example, LamB or O pF (Wong et al., Gene 68:193 [1988]), MalE, PhoA, or beta-lactamase, as well as other genes, may be used to target proteins from prokaryotic cells into the culture medium. Trafficking sequences from plants, animals and microbes can be employed in the practice of the invention to direct the monoterpene synthase proteins of the present invention to the cytoplasm, endoplasmic reticulum, mitochondria or other cellular components, or to target the protein for export to the medium.
  • suitable vectors containing DNA encoding replication sequences, regulatory sequences, phenotypic selection genes and the monoterpene synthase DNA of interest are prepared using standard recombinant DNA procedures. Isolated plasmids and DNA fragments are cleaved, tailored, and ligated together in a specific order to generate the desired vectors, as is well known in the art (see, for example, Maniatis, supra, and Sambrook et al., supra).
  • (-)-limonene synthase, (-)-pinene synthase and myrcene synthase variants are preferably produced by means of mutation(s) that are generated using the method of site-specific mutagenesis.
  • This method requires the synthesis and use of specific oligonucleotides that encode both the sequence of the desired mutation and a sufficient number of adjacent nucleotides to allow the oligonucleotide to stably hybridize to the DNA template.
  • the starting plasmids used in this invention are either commercially available, publicly available on an unrestricted basis, or can be constructed from such available plasmids using published procedures.
  • other equivalent plasmids are known in the art and will be apparent to the ordinary artisan.
  • “Digestion”, “cutting” or “cleaving” of DNA refers to catalytic cleavage of the DNA with an enzyme that acts only at particular locations in the DNA. These enzymes are called restriction endonucleases, and the site along the DNA sequence where each enzyme cleaves is called a restriction site.
  • the restriction enzymes used in this invention are commercially available and are used according to the instructions supplied by the manufacturers. (See also sections 1.60-1.61 and sections 3.38-3.39 of Sambrook et al, supra.)
  • Recovery or "isolation" of a given fragment of DNA from a restriction digest means separation of the resulting DNA fragment on a polyacrylamide or an agarose gel by electrophoresis, identification of the fragment of interest by comparison of its mobility versus that of marker DNA fragments of known molecular weight, removal of the gel section containing the desired fragment, and separation of the gel from DNA.
  • This procedure is known generally. For example, see Lawn et al. (Nucleic Acids Res. 9:6103-6114 [1982]), and Goeddel et al. (Nucleic Acids Res., supra).
  • PCR-Based Probe Generation Based on comparison of sequences of limonene synthase from spearmint (Colby, S.M., Alonso, W.R., Katahira, E.J., McGarvey, D.J., and Croteau, R. (1993) J. Biol. Chem. 268:23016- 23024), 5-ty;/-aristolochene synthase from tobacco (Facchini, P.J., and Chappell, J. (1992) Proc. Natl. Acad. Sci. USA 89:11088-11092), and casbene synthase from castor bean (Mau, C.J.D., and West, CA. (1994) Proc. Natl.
  • primer D was designed based on the conserved amino acid sequence motif DD(T/I)(I/Y/F)D(A/V)Y(A/G)(SEQ ID NO:25) of the above noted terpene synthases (Colby, S.M., Alonso, W.R., Katahira, E.J., McGarvey, D.J., and Croteau, R. (1993) J. Biol. Chem. 268:23016-23024; Facchini, P.J., and Chappell, J. (1992) Proc. Natl. Acad. Sci. USA 89:11088-11092; Mau, C.J.D., and West, CA. (1994) Proc. Natl. Acad. Sci. USA 91:8497-8501).
  • PCR was performed in a total volume of 50 ⁇ l containing 20 mM Tris/HCl (tris(hydroxymethyl) aminomethane/HCl, pH 8.4), 50 mM KC1, 5 mM MgCl 2 , 200 ⁇ M of each dNTP, 1-5 ⁇ M of each primer, 2.5 units of Taq polymerase (BRL) and 5 ⁇ l of purified Grand fir
  • Plasmid DNA was prepared from 41 individual transformants and the inserts were sequenced (DyeDeoxy Terminator Cycle Sequencing, Applied Biosystems). Four different insert sequences were identified, and were designated as probes 1 (SEQ ID NO:l 1), 2 (SEQ ID NO: 12), 4 (SEQ ID NO: 13) and 5 (SEQ ID NO: 14). Subsequent isolation of four new cDNA species (AG1.28 (SEQ ID NO: 15);
  • GE(K/T)(V/I)M(E/D)EA (SEQ ID NO:26) and degenerate primer F (SEQ ID NO:22) was designed to conserved element Q(F/Y/D)(I/L)(T/L/R)RWW (SEQ ID NO:27) by comparing the sequences of five cloned terpene synthases from Grand fir: a monoterpene synthase corresponding to probe 2 (SEQ ID NO: 12), two sesquiterpene synthases corresponding to probe 4 (SEQ ID NO:13) and probe 5 (SEQ ID NO:14), respectively, a previously described diterpene synthase (Stofer Vogel, B., Wildung,
  • Degenerate primer G was designed according to the amino acid sequence DVIKG(F/L)NW (SEQ ID NO:28) obtained from a peptide generated by trypsin digestion of purified (-)-pinene synthase from Grand fir.
  • Primers E (SEQ ID NO:21) and F (SEQ ID NO:22) were independently used for PCR amplification in combination with primer G (SEQ ID NO:23), with Grand fir stem cDNA library as template.
  • the combination of primers E (SEQ ID NO:21) and G (SEQ ID NO:23) yielded a specific PCR product of approximately 1020 bps.
  • This PCR product was ligated into pT7Blue and transformed into E. coli XL 1 -Blue. Plasmid DNA was prepared from 20 individual transformants and inserts were sequenced from both ends. The sequence of this 1022 bp insert was identical for all 20 plasmids and was designated as probe 3 (SEQ ID NO:24).
  • EXAMPLE 2 EXAMPLE 2
  • Hybridization with probe 3 was performed as before, but the filters were washed three times for 10 min at 65 °C in 3 x SSPE and 0.1% SDS before exposure. Approximately 400 ⁇ ZAPII clones yielded strong positive signals, and 34 of these were purified through a second round of hybridization at 65°C Approximately 400 additional clones yielded weak positive signals with probe 3 (SEQ ID NO:24), and 18 of these were purified through a second round of hybridization for 20 h at 45 °C Purified ⁇ ZAP II clones isolated using all five probes were in vivo excised as Bluescript II SK(-) phagemids and transformed into E.
  • each cDNA insert was determined by PCR using T3 (SEQ ID NO:29) and T7 (SEQ ID NO:30) promoter primers and selected inserts (>1.5 kb) were partially sequenced from both ends.
  • a 2016 bp fragment extending from nucleotide 73 to nucleotide 2088 of the sequence set forth in SEQ ID NO:5 was subcloned in frame into the pSBETa vector (Schenk, P.M., Baumann, S., Mattes, R., and Steinbiss, H.-H. (1995) Biotechniques 19, 196-200).
  • fragments were amplified by PCR using primer combinations 2.2-BamUl (5 * -CAA AGG GAT CCA GAA TGG CTC TGG-3')(SEQ ID NO:33) and 2.2-Notl (5'-AGT AAG CGG CCG CTT TTT AAT CAT ACC CAC-3')(SEQ ID NO:34) with pAG2.2 insert (SEQ ID NO: l) as template, 3.18-EcoRl (5 * -CTG CAG GAA TTC GGC ACG AGC-3')(SEQ ID NO:35) and 3A8-Smal (5'-CAT AGC CCC GGG CAT AGA TTT GAG CTG-3')(SEQ ID NO:36) with pAG3.18 insert (SEQ ID NO:3) as template, and 10-Ndel (5-GGC AGG AAC ATA TGG CTC TCC TTT CTA TCG- 3')(SEQ ID NO:37) and 10-BamUl
  • PCR reactions were performed in volumes of 50 ⁇ l containing 20 mM Ti ⁇ s/I ICl (pi I 8.8), 10 mM KC1, 10 mM (NH 4 ) 2 SO 4 , 2 mM MgSO 4 , 0.1% Triton X-100, 5 ⁇ g bovine serum albumin (BSA), 200 ⁇ M of each dNTP, 0.1 ⁇ M of each primer, 2.5 units of recombinant Pfu polymerase (Stratagene) and 100 ng plasmid DNA with the following program: denaturation at 94 °C, 1 min; annealing at 60 °C, 1 min; extension at 72 °C, 3.5 min; 35 cycles with final extension at 72 °C, 5 min.
  • BSA bovine serum albumin
  • PCR products were purified by agarose gel electrophoresis and used as template for a secondary PCR amplification with the identical conditions in total volumes of 250 ⁇ l each.
  • Products from this secondary amplification were digested with the above indicated restriction enzymes, purified by ultrafiltration and then ligated, respectively, into if ⁇ mHI/ ⁇ Otl-digested pGEX-4T-2 to yield plasmid pGAG2.2, into EcoRl/Sma -digested pGEX-4T-3 to yield plasmid pGAG3.18, and into /VJel ⁇ mHI-digested pSBETa to yield plasmid pSBAGlO; these plasmids were then transformed into E. coli XL 1 -Blue or E. coli BL21(DE3).
  • 1 ml sesquiterpene synthase assay buffer [10 mM dibasic potassium phosphate, 1.8 mM monobasic potassium phosphate (pH 7.3), 140 mM NaCl, 10 mM MgCl 2 , 5 mM dithiothreitol, 0.05% (w/v) NaHSO 3 and 10% (v/v) glycerol], or 1 ml diterpene synthase assay buffer [30 mM Hepes (jV-2-hydroxyethylpiperazine-. ⁇ /'-2- elhanesulfonic acid, pH 7.2), 7.5 mM MgCl 2 , 5 mM dithiothreitol, 10 ⁇ M MnCl 2 ,
  • RNA Extraction and Northern Blotting Grand fir sapling stem tissue was harvested prior to wounding or two days after wounding by a standard procedure (Gijzen, M., Lewinsohn, E., and Croteau, R. ( 1991 ) Arch. Biochem. Biophys. 289:267-273). Total RNA was isolated (Lewinsohn, E., Steele, C.L., and Croteau, R. (1994) Plant Mol. Biol. Rep. 12:20-25) and 20 ⁇ g of RNA per gel lane was separated under denaturing conditions (Sambrock, J., Fritsch, E.F., and Maniatis, T.
  • the probes were randomly labeled with [ ⁇ - 32 P]dATP (Feinberg, A.P., and Vogelstein, B. (1984) Anal. Biochem. 137:266-267). Blots were hybridized for 24 h at 55°C in 3 x SSPE and 0.1% SDS, washed at 55°C in 1 x SSPE and 0.1%, SDS and subjected to autoradiography as described above at -80°C for 24 h.
  • Grand fir has been developed as a model system for the study of induced oleoresin production in conifers in response to wounding and insect attack (Johnson, M.A., and Croteau, R. (1987) in Ecology and Metabolism of Plant Lipids (Fuller, G., and Nes, W.D., eds) pp. 76-91, American Chemical Society Symposium Series 325, Washington, DC; Gijzen, M., Lewinsohn, E., Savage, T.J., and Croteau, R.B.
  • Clone AG1.28 (SEQ ID NO:15)(2424 bps) includes an open reading frame (ORF) of 2350 nucleotides (nts) encoding 782 amino acids (SEQ ID NO: 16); clone AG2.2 (SEQ ID NO:l)(2196 bps), includes an ORF of 1881 nts encoding 627 amino acids (SEQ ID NO:2); clone AG4.30 (SEQ ID NO: 17)(1967 bps) includes an ORF of 1731 nts encoding 577 amino acids (SEQ ID NO: 18) and clone AG5.9 (SEQ ID NO:19)(1416 bps) includes an ORF of 1194 nucleotides encoding 398 amino acids (SEQ ID NO:20). cDNA clones AG1.28 (SEQ ID NO: 15), AG2.2 (SEQ ID NO:l), AG4.30
  • Clones AG4.30 (SEQ ID NO: 17) and AG5.9 (SEQ ID NO: 19) share approximately 80% similarity (60% identity) at the amino acid level, and are almost equally distant from both clone AG1.28 (SEQ ID NO: 15) and full-length clone AG2.2 (SEQ ID NO:l)(range of 65-70% similarity and 45-47% identity); the amino acid sequence similarity between AG1.28 (SEQ ID NO: 15) and AG2.2 (SEQ ID NO:l) is 65% (41% identity).
  • primer G (SEQ ID NO:23) was designed based upon very limited amino acid sequence information from pinene synthase (see Example 1). Only the combination of primers E (SEQ ID NO:21) and G (SEQ ID NO:23) amplified a specific product of 533 bps, which was designated as probe 3 (SEQ ID NO:24). Hybridization of 10 5 Grand fir ⁇ ZAP II cDNA clones with probe 3 (SEQ ID NO:24).
  • AGIO (SEQ ID NO:5)(2089 bp insert with ORF of 1911 nt; encoded protein of 637 residues at 73,477 Da and pi of 6.4). AG3.18 (SEQ ID NO:3) and AGIO (SEQ ID NO:4)
  • AGIO (SEQ ID NO:5) encode N-terminal sequences of 60 to 70 amino acids which are rich in serine (19-22%) and 11-15%), respectively) and low in acidic residues (4 and 2, respectively) characteristic of plastid transit peptides (Keegstra, K., Olsen, J.J., and Theg, S.M. (1989) Annu. Rev. Plant Physiol Plant Mol. Biol. 40:471-501; von Heijne, G., Stepphuhn, J., and Herrmann (1989) Eur. J. Biochem. 180:535-545).
  • Plasmid pAG3.18 (SEQ ID ⁇ O:3) contained the presumptive terpene synthase ORF in frame for direct expression from the bluescript plasmid, whereas the 9/02030
  • AGIO SEQ ID NO:5 ORF was in reversed orientation. Both AG3.18 (SEQ ID NO:3) and AGIO (SEQ ID NO:5) were subcloned into expression vectors yielding plasmids pGAG3.18 and pSBAGlO. Recombinant proteins were expressed in bacterial strain E. coli XLOLR/pAG3.18, E. coli XLl-Blue/pGAG3T8 and E. coli BL21(DE3)/pSBAG10. When extracts of the induced cells were tested for te ⁇ ene synthase activity with all of the potential prenyl diphosphate substrates, only geranyl diphosphate was utilized. Extracts from E.
  • coli BL21(DE3)/pSBAG10 converted geranyl diphosphate to limonene as the major product with lesser amounts of ⁇ -pinene, ⁇ -pinene and ⁇ -phellandrene, as determined by radio-GLC and combined GLC-MS (FIGURE 5).
  • Chiral phase capillary GLC on ⁇ -cyclodextrin revealed the limonene product to be the (-)-45'-enantiomer and the pinene products to be the related (-)-(15":55 -enantiomers.
  • coli XLl-Blue/pGAG3.18 demonstrated the presence of a 42:58% mixture of ⁇ -pinene and ⁇ -pinene (FIGURE 4), the same product ratio previously described for the purified, native (-)-pinene synthase from Grand fir (Lewinsohn, E., Gijzen, M., and Croteau, R. (1992) Arch. Biochem. Biophys. 293:167-173).
  • Chiral phase capillary GLC confirmed the products of the recombinant pinene synthase to be the (-)-(15 , :55)-enantiomers, as expected.
  • the calculated molecular weight of the (-)-pinene synthase deduced from AG3.18 is approximately 64,000 (excluding the putative transit peptide), which agrees well with the molecular weight of 63,000 established for the native enzyme from Grand fir by gel permeation chromatography and SDS-PAGE (Lewinsohn, E., Gijzen, M., and Croteau, R. (1992) Arch. Biochem. Biophys. 293:167-173).
  • a limonene synthase cDNA has thus far been cloned only from two very closely related angiosperm species (Colby, S.M., Alonso, W.R., Katahira, E.J., McGarvey, D.J., and Croteau, R. (1993) J. Biol. Chem. 268:23016-23024; Yuba, A., Yazaki, K., Tabata, M., Honda, G., and Croteau, R. (1996) Arch. Biochem. Biophys. 332:280-287), and the isolation of a pinene synthase cDNA has not been reported before.
  • Pinene synthase has previously received considerable attention as a major defense-related monoterpene synthase in conifers (Gijzen, M., Lewinsohn, E., and Croteau, R. (1991) Arch. Biochem. Biophys. 289:267-273; Lewinsohn, E., Gijzen, M., and Croteau, R. (1992) Arch. Biochem. Biophys. 293:167-173).
  • Grand fir cDNA library which was synthesized from mRNA obtained from wound- induced sapling stems, clones corresponding to pinene synthase are at least ten times more abundant than clones for myrcene synthase.
  • FIG. 6 Northern blots (FIGURE 6) of total RNA extracted from non-wounded sapling stems and from stems two days after wounding (when enzyme activity first appears) were probed with cDNA fragments for AG2.2 (SEQ ID NOT), AG3.18 (SEQ ID NO:3) and AGIO (SEQ ID NO:5), and thus demonstrated that increased mRNA accumulation for monoterpene synthases is responsible for this induced, defensive response in Grand fir.
  • the availability of cloned, defense-related monoterpene synthases presents several possible avenues for transgenic manipulation of oleoresin composition to improve tree resistance to bark beetles and other pests. For example, altering the 99/02030
  • monoterpene content of oleoresin may chemically disguise the host and decrease insect aggregation by changing the levels of pheromone precursors or predator attractants, or lower infestation by increasing toxicity toward beetles and their pathogenic fungal associates (Johnson, M.A., and Croteau, R. (1987) in Ecology and Metabolism of Plant Lipids (Fuller, G., and Nes, W.D., eds) pp. 76-91, American Chemical Society Symposium Series 325, Washington, DC; Gijzen, M., Lewinsohn, E., Savage, T.J., and Croteau, R.B.
  • cDNA cloning and functional expression of the myrcene, limonene and pinene synthases from Grand fir represent the first example of the isolation of multiple synthase genes from the same species, and provide tools for evaluation of structure-function relationships in the construction of acyclic, monocyclic and bicyclic monoterpene products and for detailed comparison to catalysts from phylogenetically distant plants that carry out ostensibly identical reactions (Gambliel, IT, and Croteau, R. (1984) J. Biol Chem. 259:740-748; Rajaonarivony, J.I.M., Gershenzon, J., and Croteau, R. (1992) Arch. Biochem. Biophys.
  • EXAMPLE 10 Alteration of Monoterpene Levels and Composition in Plant Seeds
  • the methods involve transforming a plant cell with a nucleic acid sequence encoding at least one gymnosperm monoterpene synthase, such as those encoded by the nucleic acid sequences set forth in SEQ ID NOT, SEQ ID NO:3 and SEQ ID NO:5.
  • This has the effect of altering monote ⁇ ene biosynthesis, thereby increasing the production of monoterpenes, as well as providing novel seed oils having desirable monoterpene compositions.
  • the transformed seed provides a factory for the production of modified oils.
  • the modified oil itself may be used and/or the compounds in the oils can be isolated.
  • the present invention allows for the production of particular monoterpenes of interest as well as speciality oils.
  • the nucleic acid encoding the monoterpene synthases of the present invention can be used in expression cassettes for expression in the transformed plant tissues.
  • the plant is transformed with at least one expression cassette comprising a transcriptional initiation region linked to a nucleic acid sequence encoding a monoterpene synthase.
  • Such an expression cassette is provided with a plurality of restriction sites for insertion of the nucleic acid sequence encoding a monoterpene synthase so that it is under the transcriptional regulation of the regulatory regions.
  • the transcriptional initiation sequence may be native or analogous to the host or foreign or heterologous to the host.
  • the term “foreign” means that the transcriptional initiation sequence is not found in the wild-type host into which the transcriptional initiation region is introduced.
  • transcriptional cassette will preferably include, in the 5' to 3' direction of transcription, a transcriptional and translational initiation region, a gymnosperm monoterpene synthase DNA sequence of interest, and a transcriptional and translational termination region functional in plants.
  • the termination region may be from the same organism as the transcriptional initiation region, may be from the same organism as the monoterpene synthase DNA, or may be derived from another source.
  • Convenient termination regions are available from the Ti-plasmid of A. tumefaciens, such as the octopine synthase and nopaline synthase termination regions. Other termination sequences are set forth in Guerineau et al., (1991), Mol. Gen.
  • a nucleic acid sequence encoding a gymnosperm monoterpene synthase protein will be targeted to plastids, such as chloroplasts, for expression.
  • the nucleic acid sequence, or sequences, encoding a gymnosperm monoterpene synthase protein, or proteins may be inserted into the plastid for expression with appropriate plastid constructs and regulatory elements.
  • nuclear transformation may be used in which case the expression cassette will contain a nucleic acid sequence encoding a transit peptide to direct the monoterpene biosynthesis enzyme of interest to the plastid.
  • transit peptides are known in the art. See, for example, Von Heijne et al.
  • Nucleic acid sequences encoding gymnosperm monote ⁇ ene synthases of the present invention may utilize native or heterologous transit peptides.
  • the construct may also include any other necessary regulators such as plant translational consensus sequences (Joshi, C.P., (1987), Nucleic Acids Research,
  • Translation leaders are known in the art and include: picornavirus leaders, for example, EMCV leader (Encephalomyocarditis 5' noncoding region) (Elroy-Stein, O., Fuerst, T.R., and Moss, B. (1989) PNAS USA 86:6126-6130); potyvirus leaders, for example, TEV leader (Tobacco Etch Virus) (Allison et al. (1986); MDMV leader (Maize Dwarf Mosaic Virus); Virology, 154:9- 20), and human immunoglobulin heavy-chain binding protein (BiP), (Macejak, D.G., and Sarnow, P.
  • picornavirus leaders for example, EMCV leader (Encephalomyocarditis 5' noncoding region) (Elroy-Stein, O., Fuerst, T.R., and Moss, B. (1989) PNAS USA 86:6126-6130); potyvirus leaders, for example, TEV leader (Tobacco Et
  • the sequence of interest may be desirable to synthesize the sequence with plant preferred codons, or alternatively with chloroplast preferred codons.
  • the plant preferred codons may be determined from the codons of highest frequency in the proteins expressed in the largest amount in the particular plant species of interest. See, EPA 0359472; EPA 0385962; WO 91/16432; Perlak et al. (1991) Proc. Natl. Acad. Sci. USA 88:3324-3328; and Murray et al. (1989) Nucleic Acids Research 17:477-498. In this manner, the nucleotide sequences can be optimized for expression in any plant.
  • nucleic acid sequence encoding a gymnosperm monoterpene synthase protein may be optimized or synthetic. That is, synthetic or partially optimized sequences may also be used.
  • synthetic or partially optimized sequences may also be used.
  • chloroplast preferred genes see U.S. Patent No. 5,545,817.
  • the various DNA fragments may be manipulated, so as to provide for the DNA sequences in the proper orientation and in the proper reading frame.
  • adapters or linkers may be employed to join the DNA fragments or other manipulations may be involved to provide for convenient restriction sites, removal of superfluous DNA, removal of restriction sites, or the like.
  • in vitro mutagenesis, primer repair, restriction, annealing, resection, ligati ⁇ n, or the like may be employed, where insertions, deletions or substitutions, such as transitions and transversions, may be involved.
  • the recombinant DNA molecules of the invention can be introduced into the plant cell in a number of art-recognized ways. Those skilled in the art will appreciate that the choice of method might depend on the type of plant, i.e., monocot or dicot, targeted for transformation. Suitable methods of transforming plant cells include microinjection (Crossway et al. (1986) BioTechniques 4:320-334), electroporation (Riggs et al. (1986) Proc. Natl. Acad. Sci. USA 83:5602-5606), Agrobacterium mediated transformation (Hinchee et al.
  • a plant plastid can be transformed directly. Stable transformation of chloroplasts has been reported in higher plants, see, for example, SVAB et al. (1990) Proc. Nat'l. Acad. Sci. USA 87:85268530; SVAB & Maliga (1993) Proc. Natl. Acad. Sci. USA 90:913-917; Staub & Maliga (1993) Embo J. 12:601-606.
  • the method relies on particle gun delivery of DNA containing a selectable marker and targeting of the DNA to the plastid genome through homologous recombination.
  • plastid gene expression can be accomplished by use of a plastid gene promoter or by trans-activation of a silent plastid-borne transgene positioned for expression from a selective promoter sequence such as that recognized by T7 RNA polymerase.
  • the silent plastid gene is activated by expression of the specific RNA polymerase from a nuclear expression construct and targeting of the polymerase to the plastid by use of a transit peptide.
  • Tissue- specific expression may be obtained in such a method by use of a nuclear-encoded and plastid-directed specific RNA polymerase expressed from a suitable plant tissue specific promoter.
  • the cells which have been transformed may be grown into plants by a variety of art-recognized means. See, for example, McConnick et al., Plant Cell Reports (1986), 5:81-84. These plants may then be grown, and either selfed or crossed with a different plant strain, and the resulting homozygotes or hybrids having the desired phenotypic characteristic identified. Two or more generations may be grown to ensure that the subject phenotypic characteristic is stably maintained and inherited and then seeds harvested to ensure the desired phenotype or other property has been achieved.
  • any plant variety may be employed. Of particular interest, are plant species which provide seeds of commercial value. For the most part, plants will be chosen where the seed is produced in high amounts, a seed-specific product of interest is involved, or the seed or a seed part is edible.
  • Seeds of interest in the practice of the present invention include, but are not limited to, the oil seeds, such as oilseed Brassica seeds, cotton seeds, soybean, safflower, sunflower, coconut, palm, and the like; grain seeds such as wheat, barley, oats, amaranth, flax, rye, triticale, rice and corn; other edible seeds or seeds with edible parts including pumpkin, squash, sesame, poppy, grape, mung beans, peanut, peas, beans, radish, alfalfa, cocoa, and coffee; and tree nuts such as walnuts, almonds, pecans, and chick-peas.
  • the oil seeds such as oilseed Brassica seeds, cotton seeds, soybean, safflower, sunflower, coconut, palm, and the like
  • grain seeds such as wheat, barley, oats, amaranth, flax, rye, triticale, rice and corn
  • other edible seeds or seeds with edible parts including pumpkin, squash, sesame, poppy, grape, m
  • EXAMPLE 11 A Strategy for Cloning Gymnosperm Monoterpene Synthases
  • the present invention includes gymnosperm monoterpene synthase proteins, and nucleic acid molecules that encode gymnosperm monoterpene synthase proteins.
  • the amino acid sequence of each of the gymnosperm monote ⁇ ene synthase proteins of the present invention each includes al least one of the amino acid sequence elements disclosed in Table 1.
  • the numbers set forth in Table 1 for the first and last amino acid residue of each of the peptide sequences is the number of the corresponding amino acid residue in the amino acid sequence of the (-)-pinene synthase (SEQ ID NO:4) isolated from Abies grandis.
  • SEQ ID NO:4 amino acid sequence of the (-)-pinene synthase isolated from Abies grandis.
  • brackets e.g., (L,IN) in Table 1
  • the first amino acid residue within the brackets is the residue that appears in the (-)-pinene synthase amino acid sequence set forth in SEQ ID ⁇ O:4.
  • the subsequent amino acid residues within the brackets represent other amino acid residues that commonly occur at the corresponding position in the amino acid sequence of other Abies grandis enzymes involved in te ⁇ ene synthesis.
  • the letter “F” refers to the forward PCR reaction, i.e., the PCR reaction which synthesizes the sense nucleic acid strand that encodes a gymnosperm monote ⁇ ene synthase.
  • the letter “R” refers to the reverse PCR reaction, i.e., the PCR reaction that synthesizes the antisense nucleic acid molecule that is complementary to the sense nucleic acid strand synthesized in the forward PCR reaction.
  • one or more oligonucleotide molecules corresponding to at least a portion of one of the amino acid sequences set forth in Table 1 can be used as a probe or probes with which to screen a genomic or cDNA library derived from one or more gymnosperm species.
  • the term "corresponding,” or “correspond” or “corresponds,” means that the oligonucleotide base sequence either a) encodes all or part of at least one of the amino acid sequences set forth in Table 1, or b) is complementary to a base sequence that encodes all or part of at least one of the amino acid sequences set forth in Table 1.
  • the oligonucleotide probe(s) may contain a synthetic base, such as inosine, which can be substituted for one or more of the four, naturally-occurring bases, i.e., adenine ("A"), guanine ("G”), cytosine ("C") and thymine (“T”).
  • adenine A
  • G guanine
  • C cytosine
  • T thymine
  • the following oligonucleotide sequences “correspond" to the tripeptide sequence M M M: 5 ⁇ TGATGATG3' (sense orientation) (SEQ ID NO:54); 3 ACTACTAC5' (antisense orientation) (SEQ ID NO:55) and 3'IACIACIAC5' (SEQ ID NO:56).
  • One or more oligonucleotide sequence(s), corresponding to at least a portion of at least one of the amino acid sequences set forth in Table 1 can be used to screen a nucleic acid library in order to identify monoterpene synthase clones of the present invention, according to methods well known to one of ordinary skill in the art. See, e.g., Sambrook et al, supra.
  • the stringency of the hybridization and wash conditions during library screening in accordance with the present invention is at least: for the hybridization step, 6X SSPE, 40-45°C, for 36 hours; for the wash step, 3X SSPE, 45°C, 3 X 15 minute washes.
  • the presently preferred hybridization and wash conditions during library screening, utilizing one or more oligonucleotide sequence(s) corresponding to at least a portion of at least one of the amino acid sequences set forth in Table 1, in accordance with the present invention are: for the hybridization step, 6X SSPE, 40- 45°C, for 36 hours; for the wash step, 0.1X SSPE, 65°C-70°C, 3 X 15 minute washes.
  • oligonucleotide sequences corresponding to at least one of the amino acid sequences set forth in Table 1, that hybridize, under the foregoing hybridization and wash conditions, to the sense strands of the nucleic acid sequences of the present invention that encode gymnosperm monote ⁇ ene synthase proteins are set forth in Table 2.
  • Table 2 Examples of oligonucleotide sequences, corresponding to at least one of the amino acid sequences set forth in Table 1, that hybridize, under the foregoing hybridization and wash conditions, to the sense strands of the nucleic acid sequences of the present invention that encode gymnosperm monote ⁇ ene synthase proteins are set forth in Table 2.
  • each of the gymnosperm monote ⁇ ene synthase clones set forth in SEQ ID NOT, SEQ ID NO: 3 and SEQ ID NO: 5, or a portion thereof may be used as a probe to screen a nucleic acid library in order to isolate monote ⁇ ene synthase clones of the present invention, according to methods well known to one of ordinary skill in the art. See, e.g., Sambrook et al, supra.
  • the stringency of the hybridization and wash conditions during library screening in accordance with the present invention is at least: for the hybridization step, 6X SSPE buffer at 45°C to 50°C for 36 hours; for the wash step, 3X SSPE buffer at 50°C (three, fifteen minute washes).
  • the presently preferred hybridization and wash conditions during library screening utilizing any of the gymnosperm monote ⁇ ene synthase clones set forth in SEQ ID NOT, SEQ ID NO:3 and SEQ ID NO: 5, or a portion thereof, as probe are: for the hybridization step, 6X SSPE, 40- 45°C, for 36 hours; for the wash step, 0.1X SSPE, 70°C-75°C, 3 X 15 minute washes.
  • oligonucleotide sequence(s) each corresponding to at least a portion of at least one of the amino acid sequences set forth in Table 1 , can be used in a PCR reaction to generate a portion of a monote ⁇ ene synthase clone of the present invention, which can be used as a probe to isolate a full-length clone of a monote ⁇ ene synthase clone of the present invention.
  • oligonucleotides that are useful as probes in the forward PCR reaction correspond to at least a portion of at least one of the amino acid sequences disclosed in Table 1 as having the "F" orientation.
  • oligonucleotides that are useful as probes in the reverse PCR reaction correspond to at least a portion of at least one of the amino acid sequences disclosed in Table 1 as having the "R" orientation.
  • PCR reactions can be carried out according to art-recognized PCR reaction conditions, such as the PCR reaction conditions set forth in Example 1 herein and as set forth in "PCR Strategies", M.A. Innis, D.H. Gelfand and J.J. Sninsky, eds., 1995, Academic Press, San Diego, CA (Chapter 14); "PCR Protocols: A Guide to Methods and Applications", M.A. Innis, D.H. Gelfand, J.J. Sninsky and TJ. White, eds., Academic Press, NY (1990).
  • the presently preferred PCR reaction conditions are:
  • thermocycler conditions are:

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

On a isolé et séquencé des ADNc codant la myrcène synthase, (-)-limonène synthase et (-)-pinène synthase tirée du sapin grandissime (Abies grandis) et on a déterminé les séquences d'acides aminés correspondantes. Par conséquent, l'invention concerne les séquences d'ADN isolées (SEQ ID NO:1; SEQ ID NO:3 ET SEQ ID NO:5) codant pour l'expresssion de myrcène synthase (SEQ ID NO:2), (-)-pinène synthase (SEQ ID NO:4) et (-)-limonène synthase (SEQ ID NO:6), respectivement, tirées du sapin grandissime (Abies grandis). Dans d'autres aspects, l'invention concerne des véhicules de clonage recombinés réplicables codant pour la myrcène synthase, la (-)-limonène synthase et la (-)-pinène synthase, ou pour une séquence de base suffisamment complémentaire d'au moins une partie d'ADN ou d'ARN de myrcène synthase, de (-)-limonène synthase ou de (-)-pinène synthase afin de permettre une hybridation avec ceux-ci. Dans d'autres aspects, l'invention concerne des cellules hôtes modifiées ayant été transformées, transfectées, infectées et/ou injectées avec un véhicule de clonage recombiné et/ou une séquence d'ADN codant la myrcène synthase, la (-)-limonène synthase ou la (-)-pinène synthase. Ainsi, on obtient des systèmes et des procédés d'expression recombinée de monoterpènes synthases recombinées pré-citées pouvant être utilisées pour faciliter leur reproduction, isolement et purification en quantités significatives. On peut utiliser les myrcène synthase (-)-limonène synthase ou (-)-pinène synthase recombinées pour obtenir une expression ou une expression améliorée de myrcène synthase, (-)-limonène synthase ou (-)-pinène synthase dans des plantes afin d'améliorer la production de monoterpènoïdes, ou on peut également les utiliser à la régulation ou à l'expression de myrcène synthase, (-)-limonène synthase et (-)-pinène synthase ou dans la production de leurs produits.
PCT/US1998/014528 1997-07-11 1998-07-10 MONOTERPENES SYNTHASES TIREES DE SAPIN GRANDISSIME (Abies grandis) WO1999002030A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU84839/98A AU8483998A (en) 1997-07-11 1998-07-10 Monoterpene synthases from grand fir ((abies grandis))
EP98935641A EP1032257A4 (fr) 1997-07-11 1998-07-10 MONOTERPENES SYNTHASES TIREES DE SAPIN GRANDISSIME ($i(Abies grandis))
CA002296664A CA2296664A1 (fr) 1997-07-11 1998-07-10 Monoterpenes synthases tirees de sapin grandissime (abies grandis)
US09/360,545 US6429014B1 (en) 1997-07-11 1999-07-26 Monoterpene synthases from grand fir (Abies grandis)
PCT/US2000/020264 WO2001007565A2 (fr) 1997-07-11 2000-07-24 Synthetases de monoterpene produites a partir du sapin grandissime (abies grandis)
US10/025,145 US20030175861A1 (en) 1997-07-11 2001-12-19 Monoterpene synthases from grand fir (abies grandis)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5224997P 1997-07-11 1997-07-11
US60/052,249 1997-07-11

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US09/360,545 Continuation-In-Part US6429014B1 (en) 1997-07-11 1999-07-26 Monoterpene synthases from grand fir (Abies grandis)

Publications (1)

Publication Number Publication Date
WO1999002030A1 true WO1999002030A1 (fr) 1999-01-21

Family

ID=21976364

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/014528 WO1999002030A1 (fr) 1997-07-11 1998-07-10 MONOTERPENES SYNTHASES TIREES DE SAPIN GRANDISSIME (Abies grandis)

Country Status (5)

Country Link
EP (1) EP1032257A4 (fr)
AU (1) AU8483998A (fr)
CA (1) CA2296664A1 (fr)
TW (1) TW585918B (fr)
WO (1) WO1999002030A1 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1049370A1 (fr) * 1998-01-22 2000-11-08 Washington State University Research Foundation SESQUITERENE SYNTHASES TIREES DU SAPIN GRANDISSIME $i(ABIES GRANDIS) ET PROCEDES D'UTILISATION
WO2002020815A2 (fr) * 2000-09-01 2002-03-14 E.I. Dupont De Nemours And Company Production de terpenoides cycliques
EP1220899A2 (fr) * 1999-07-26 2002-07-10 Washington State University Research Foundation Synthetases de monoterpene produites a partir du sapin grandissime (abies grandis)
US6468772B1 (en) 1998-09-18 2002-10-22 The Salk Institute For Biological Studies Methods of making modified polypeptides
EP2850193A4 (fr) * 2012-05-11 2016-05-11 Donald Danforth Plant Sci Ct Procédés de production à haut rendement de terpènes
US9550815B2 (en) 2012-01-23 2017-01-24 University Of British Columbia ABC terpenoid transporters and methods of using the same
WO2017075538A1 (fr) * 2015-10-29 2017-05-04 Amyris, Inc. Compositions et procédés permettant la production de myrcène
CN113169899B (zh) * 2018-11-08 2024-03-05 瑞典爱立信有限公司 确定网络服务（ns）的规模

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948811A (en) * 1988-01-26 1990-08-14 The Procter & Gamble Company Salad/cooking oil balanced for health benefits
WO1995011913A1 (fr) * 1993-10-28 1995-05-04 Washington State University Research Foundation ADN CODANT LA LIMONENE SYNTHASE PROVENANT DE LA $i(MENTHA SPICATA)

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948811A (en) * 1988-01-26 1990-08-14 The Procter & Gamble Company Salad/cooking oil balanced for health benefits
WO1995011913A1 (fr) * 1993-10-28 1995-05-04 Washington State University Research Foundation ADN CODANT LA LIMONENE SYNTHASE PROVENANT DE LA $i(MENTHA SPICATA)

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BOHLMANN J., ET AL.: "TERPENOID-BASED DEFENSES IN CONIFERS: CDNA CLONING, CHARACTERIZATION, AND FUNCTIONAL EXPRESSION OF WOUND-INDUCIBLE (E)-ALPHA-BISABOLENE SYNTHASE FROM GRAND FIR (ABIES GRANDIS).", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 95., no. 12., 1 June 1998 (1998-06-01), US, pages 6756 - 6761., XP002914704, ISSN: 0027-8424, DOI: 10.1073/pnas.95.12.6756 *
BOHLMANN J., STEELS C., CROTEAU R.: "MONOTERPENE SYNTHASES FROM GRAND FIR (ABIES GRANDIS). CDNA ISOLATION, CHARACTERIZATION, AND FUNCTIONAL EXPRESSION OF MYRCENE SYNTHASE,(-)-(RS)-LIMONENE SYNTHASE, AND (-)-(1S,5S)-PINENE SYNTHASE.", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, vol. 272., no. 35., 29 August 1997 (1997-08-29), US, pages 21784 - 21792., XP002914705, ISSN: 0021-9258, DOI: 10.1074/jbc.272.35.21784 *
COLBY S. M., ET AL.: "4S-LIMONENE SYNTHASE FROM THE OIL GLANDS OF SPEARMINT (MENTHA SPICATA).", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, vol. 268., no. 31., 5 November 1993 (1993-11-05), US, pages 23016 - 23024., XP002914702, ISSN: 0021-9258 *
See also references of EP1032257A4 *
WILDUNG M. R., CROTEAU R.: "A CDNA CLONE FOR TAXADIENE SYNTHASE, THE DITERPENE CYCLASE THAT CATALYZES THE COMMITTED STEP OF TAXOL BIOSYNTHESIS.", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, vol. 271., no. 16., 19 April 1996 (1996-04-19), US, pages 9201 - 9204., XP002914701, ISSN: 0021-9258, DOI: 10.1074/jbc.271.38.23262 *
YUBA A., ET AL.: "CDNA CLONING, CHARACTERIZATION, AND FUNCTIONAL EXPRESSION OF 4S- (-)-LIMONENE SYNTHASE FROM PERILLA FRUTESCENS 1,2.", ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, ACADEMIC PRESS, US, vol. 332., no. 21., 15 August 1996 (1996-08-15), US, pages 280 - 287., XP002914703, ISSN: 0003-9861, DOI: 10.1006/abbi.1996.0343 *

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1049370A1 (fr) * 1998-01-22 2000-11-08 Washington State University Research Foundation SESQUITERENE SYNTHASES TIREES DU SAPIN GRANDISSIME $i(ABIES GRANDIS) ET PROCEDES D'UTILISATION
EP1049370A4 (fr) * 1998-01-22 2004-10-06 Univ Washington SESQUITERENE SYNTHASES TIREES DU SAPIN GRANDISSIME $i(ABIES GRANDIS) ET PROCEDES D'UTILISATION
US6495354B2 (en) 1998-09-18 2002-12-17 University Of Kentucky Research Foundation Synthases
US6890752B2 (en) 1998-09-18 2005-05-10 The University Of Kentucky Research Foundation Synthases
US6468772B1 (en) 1998-09-18 2002-10-22 The Salk Institute For Biological Studies Methods of making modified polypeptides
US6569656B2 (en) 1998-09-18 2003-05-27 The University Of Kentucky Research Foundation Synthases
US6559297B2 (en) 1998-09-18 2003-05-06 The Salk Institute For Biological Studies Synthases
EP1220899A4 (fr) * 1999-07-26 2005-03-16 Univ Washington Synthetases de monoterpene produites a partir du sapin grandissime (abies grandis)
EP1220899A2 (fr) * 1999-07-26 2002-07-10 Washington State University Research Foundation Synthetases de monoterpene produites a partir du sapin grandissime (abies grandis)
WO2002020815A3 (fr) * 2000-09-01 2003-02-06 Du Pont Production de terpenoides cycliques
WO2002020815A2 (fr) * 2000-09-01 2002-03-14 E.I. Dupont De Nemours And Company Production de terpenoides cycliques
US6818424B2 (en) 2000-09-01 2004-11-16 E. I. Du Pont De Nemours And Company Production of cyclic terpenoids
US9550815B2 (en) 2012-01-23 2017-01-24 University Of British Columbia ABC terpenoid transporters and methods of using the same
EP2850193A4 (fr) * 2012-05-11 2016-05-11 Donald Danforth Plant Sci Ct Procédés de production à haut rendement de terpènes
WO2017075538A1 (fr) * 2015-10-29 2017-05-04 Amyris, Inc. Compositions et procédés permettant la production de myrcène
CN108779468A (zh) * 2015-10-29 2018-11-09 阿迈瑞斯公司 生成月桂烯的组合物和方法
US11085046B2 (en) 2015-10-29 2021-08-10 Amyris, Inc. Compositions and methods for production of myrcene
US11767533B2 (en) 2015-10-29 2023-09-26 Amyris, Inc. Compositions and methods for production of myrcene
CN113169899B (zh) * 2018-11-08 2024-03-05 瑞典爱立信有限公司 确定网络服务（ns）的规模

Also Published As

Publication number Publication date
CA2296664A1 (fr) 1999-01-21
AU8483998A (en) 1999-02-08
EP1032257A1 (fr) 2000-09-06
TW585918B (en) 2004-05-01
EP1032257A4 (fr) 2005-03-16

Similar Documents

Publication Publication Date Title
US8017386B2 (en) Divinyl ether synthase gene and protein, and uses thereof
EP1171610A1 (fr) Sequences d'acide nucleique et proteines intervenant dans la synthese de l'isoprenoide
AU741393B2 (en) Geranyl diphosphate synthase from mint (mentha piperita)
WO1999011757A1 (fr) SEQUENCES D'ACIDES NUCLEIQUES ET AMINES, DESTINEES A UNE NOUVELLE TRANSKETOLASE EXTRAITE DE $i(MENTHA PIPERITA)
AU741619B2 (en) Monoterpene synthases from common sage (salvia officinalis)
AU747075B2 (en) Sesquiterpene synthases from grand fir abies grandis, and methods of use
US6429014B1 (en) Monoterpene synthases from grand fir (Abies grandis)
WO1999002030A1 (fr) MONOTERPENES SYNTHASES TIREES DE SAPIN GRANDISSIME (Abies grandis)
AU747746B2 (en) Isolation and expression of farnesene synthase from peppermint, mentha x piperita, L.
CA2387734A1 (fr) Sous-unite de grande dimension de geranyl diphosphate synthetase, et procedes d'utilisation
WO2005021705A2 (fr) Sesquiterpene synthase d'agrume, procedes de production et utilisations correspondantes
US20060137032A1 (en) Plant alpha farnesene synthase and polynucleotides encoding same
EP1220899A2 (fr) Synthetases de monoterpene produites a partir du sapin grandissime (abies grandis)
NZ521984A (en) Enzyme and polynucleotides encoding the sesquiterpene synthase, alpha-farnesene synthase
WO2006001802A1 (fr) Reductase de menthone isolee et molecules d'acides nucleiques la codant

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 09360545

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2296664

Country of ref document: CA

Ref country code: CA

Ref document number: 2296664

Kind code of ref document: A

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 1998935641

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1998935641

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1998935641

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载